SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently experiencing heightened community interest and price volatility, with investors closely monitoring its potential for institutional adoption, quantum-resistant technology, and potential regulatory classification as a commodity. Discussions are dominated by speculation regarding a market-wide rally, the project's long-term utility in the RWA (Real-World Asset) sector, and ongoing community debate over recent governance and leadership changes.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is drawing intense community focus as traders debate its potential for institutional adoption following recent network integrations and speculation surrounding upcoming regulatory clarity. Investors are actively balancing the project's long-term utility against recent price consolidation, with many using the current levels to accumulate in anticipation of potential breakthroughs.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is experiencing heightened volatility and intense social media debate ahead of its upcoming earnings report, with sentiment divided between those betting on long-term disruption through AI integration and skeptics flagging concerns over medical loss ratios and regulatory headwinds. The conversation is heavily focused on whether management's aggressive forward guidance can materialize into actual profitability, or if the stock remains vulnerable to further downward pressure despite recent institutional accumulation.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is facing intense community skepticism and frustration as the token struggles with persistent price weakness, leading some investors to label the project a failed asset while others continue to hold in hopes of a long-term turnaround. Despite ongoing development news and recent ecosystem partnerships, the discourse is dominated by polarized debates between disillusioned long-term holders and those aggressively accumulating tokens at current lows.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility versus short-term price action, with many investors closely watching the final token unlocks and the potential for major institutional partnerships at upcoming industry events. Supporters are pointing to real-world integration milestones like payroll streaming as signs of a maturing ecosystem, while skeptics remain vocal about the token's circulating supply and current market performance.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket Companies is facing heightened volatility and selling pressure as investors weigh strong earnings against macro headwinds, including geopolitical tensions and rising interest rate expectations. While some in the community are treating the decline as a generational buying opportunity based on long-term market leadership, others remain cautious, debating whether technical support levels will hold or if the stock faces further downside.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is currently at the center of polarized community debate, with bulls citing potential regulatory clarity and long-term utility while bears point to persistent price underperformance and lack of ETF momentum. Investors are intensely focused on technical price levels, with active discussions regarding a possible breakout or continued downside as sentiment remains split between long-term holding and short-term volatility.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending as investors monitor the upcoming April 10, 2026, PDUFA date for RP1 in advanced melanoma, with community sentiment split between concerns over the previous Complete Response Letter and optimism that additional data will lead to approval. Discussions frequently compare the company's regulatory path to that of Iovance, while traders debate whether the stock is currently overextended or positioned for a potential squeeze.

Maul Coin

Maul Coin is trending as the community rallies behind an active developer who is prioritizing transparency and long-term project growth over short-term flips. Investors are actively discussing the coin's potential to move past initial market cap hurdles through coordinated social media raiding and community-driven engagement.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors react to the company's recent leadership transition, with renewed attention on Greg Abel's commitment to share repurchases and personal equity investments. The community remains deeply divided, with some highlighting the company's massive cash position as a strategic 'fortress' for future opportunities, while others express frustration over stagnant performance and the lack of dividends compared to broader market growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>In February 2025, Hims &amp; Hers announced the acquisition of a peptide facility in California to meet the growing demand among Americans for personalized healthcare and treatment options.</li><li>An NYT report stated that top leaders at the FDA have reservations about peptides, according to a senior Department of Health and Human Services official.</li><li>On a recent episode of the Joe Rogan podcast, Health and Human Services Secretary Robert F. Kennedy Jr., who oversees the FDA, said he is a “big fan” of peptides.</li></ul>Hims &amp; Hers Health Inc. (HIMS) shares surged on Tuesday morning amid a report stating that the U.S. Food and Drug Administration is moving to lift restrictions on peptides.According to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/03/31/health/peptide-ban-fda-rfk-jr.html">report</a> by The New York Times, the FDA is moving to allow compounding pharmacies to manufacture over a dozen injectable peptides&nbsp;that were previously banned due to potential safety risks.This decision would reverse a 2023 ban that resulted in the removal of 14 peptides from a list of products that the FDA allowed compounding pharmacies to produce.<a href="https://stocktwits.com/symbol/HIMS">Shares of Hims &amp; Hers</a>, which provides compounded medications, surged more than 7% in Tuesday morning’s trade.<h2 class="st-heading-2">Top FDA Leaders Have Reservations About Peptides, Says Report</h2>The report added that top leaders at the FDA have reservations about peptides, according to a senior Department of Health and Human Services official. It noted that if the FDA had flagged peptides as being marketed through unproven claims of disease-fighting and cosmetic benefits.In its 2023 notification, the regulator listed several bulk drug substances, including peptides, noting that it had identified “potential significant safety risks” associated with them.<h2 class="st-heading-2">RFK Jr. Says He Is A ‘Big Fan’ Of Peptides</h2>During an episode of the Joe Rogan podcast earlier this month, Secretary of Health and Human Services Robert F. Kennedy Jr. said that he is a “big fan” of peptides. As the HHS secretary, RFK Jr. oversees the FDA.“I’ve used them myself, and used them with really good effect on a couple of injuries,” he said, while adding that during the Biden administration, 19 peptides were “illegally” moved to Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.This category prohibits compounding pharmacies from formulating compounds comprising peptides, RFK Jr. added.“There was huge demand for peptides and a black market came up, and the black market is run by companies that say the peptides are for animal use or research purposes. And that peptide now basically completely replaced the legal market,” he said.<h2 class="st-heading-2">Where Does Hims &amp; Hers Fit In This Case?</h2>Hims &amp; Hers had come&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-sues-hims-hers-permanent-ban-unapproved-compounded-drugs/cZbHzMjR4o2">under fire</a> from regulators and Novo Nordisk AS (NVO) for offering a compounded version of the company’s best-selling weight-loss pill, Wegovy.Novo Nordisk subsequently&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk">dropped</a> its lawsuit against Hims &amp; Hers and announced a partnership to offer Ozempic and Wegovy at affordable self-pay prices on the telehealth company’s platform.Earlier in February 2025, Hims &amp; Hers announced the acquisition of a peptide facility based in California to address the growing demand from Americans for personalized healthcare and treatment options.“The peptide capabilities made possible through this acquisition position the company in the coming years to explore exciting advances in peptide innovation, including across areas of consumer need such as preventive health, metabolic optimization, cognitive performance, recovery science, and biological resistance,” the company said.<h2 class="st-heading-2">What Are Peptides?</h2>Peptides are short chains of amino acids, the same building blocks that make up proteins, linked together by peptide bonds.Blockbuster weight-loss drugs Ozempic and Wegovy are also peptide medications that use glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity by&nbsp;stimulating insulin secretion.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> is down 39% year-to-date and 33% over the past 12 months. The iShares Core S&amp;P Mid-Cap ETF (IJH) is up 14% over the past 12 months, while the iShares Russell 2000 ETF (IWM) is up 22%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warren-buffett-sold-apple-shares-too-soon-berkshire/cZEPvVFRIVi">Buffett Says He Sold Apple Shares Too Soon, But Does Not Regret It: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS). (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides

This decision would reverse a 2023 ban that resulted in the removal of 14 peptides from a list of products that the FDA allowed compounding pharmacies to produce.

Equity

<ul class="summary-bullets"><li>The net proceeds to be received from the sale of common stock offered by the company will be used for general corporate purposes, among other things.&nbsp;</li><li>Avis operates as a vehicle rental operator in North America, Europe, Australasia and other regions, with an average rental fleet of approximately 684,000 vehicles in 2025.&nbsp;</li><li>Morgan Stanley earlier in the month lowered the firm's price target on Avis Budget to $97 from $142 and kept an ‘Equal Weight’ rating on the shares.</li></ul>Avis Budget Group (CAR) shares fell as much as 4% in Friday’s extended hours of trading after the&nbsp;vehicle sharing and rental services provider announced an automatic offering of its common shares.&nbsp;The company is selling its common shares via automatic offering with par value $0.01 per share.The&nbsp;company said that&nbsp;net proceeds from the offering&nbsp;would be used for general corporate purposes, including repayment of indebtedness, acquisitions, additions to working capital, repurchases of common stock, dividends, capital expenditures and investments in the company’s subsidiaries.&nbsp;Net proceeds may be temporarily invested prior to use, the company added.&nbsp;Avis Budget said that to facilitate the offering of the common stock, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of its common stock.&nbsp;<h2 class="st-heading-2">About Avis</h2>Avis operates three globally recognized brands in mobility solutions named as Avis, Budget and Zipcar. It operates as a vehicle rental operator in North America, Europe, Australasia and other regions, with an average rental fleet of approximately 684,000 vehicles in 2025.&nbsp;<h2 class="st-heading-2">Recent Analyst Actions</h2>Morgan Stanley earlier in the month lowered the firm's price target on Avis Budget to $97 from $142 and kept an ‘Equal Weight’ rating on the shares. The firm updated its rental car estimates post Q4, lowering its targets for Avis after what it called "much weaker than expected results and guidance."Deutsche Bank also lowered the firm's price target on Avis Budget to $128 from $148 and kept a ‘Buy’ rating on the shares.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around CAR trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares of CAR have risen 15% so far this year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

A person views trading stocks on a tablet on the last day of the 2025 trading market in Brussels, Belgium, on December 30, 2025.

Avis Budget Stock Tanks After Hours – What’s Driving It Down?

 The company is selling its common shares via automatic offering with par value $0.01 per share.

<ul class="summary-bullets"><li>Its net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter.</li><li>However, adjusted earnings per share of $0.49 for the fourth quarter ended January 31, 2026, easily surpassed Wall Street consensus of $0.37 as per Stocktwits data.</li></ul>GameStop (<a href="https://stocktwits.com/symbol/GME">GME</a>) shares fell as much as 5% during Tuesday’s extended hours of trading after the video game retailer reported its fourth quarter earnings.&nbsp;The company reported a decline in its fourth quarter net sales. Its net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Analysts on average expected net sales of $1.47 billion, according to data from Stocktwits.&nbsp;<h2 class="st-heading-2">More Details</h2>The company posted adjusted earnings per share of $0.49 for the fourth quarter ended January 31, 2026, easily surpassing Wall Street consensus of $0.37 as per Stocktwits data.&nbsp;GME reported operating income of $135.2 million for the fourth quarter, compared to $79.8 million in the prior year's fourth quarter.&nbsp;Cash, cash equivalents and marketable securities were $9.0 billion at the close of the quarter compared to $4.8 billion at the close of the prior year's fourth quarter. GME’s Bitcoin and related receivables were valued at $368.4 million at the close of the quarter.<h2 class="st-heading-2">Full Year&nbsp;</h2>The company posted net sales of $3.630 billion for fiscal year 2025, compared to $3.823 billion in fiscal year 2024.&nbsp;GME posted an operating income of $232.1 million for the year, compared to an operating loss of $26.2 million in fiscal year 2024. Its net income was $418.4 million for fiscal year 2025, compared to $131.3 million from the previous year.&nbsp;<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around GME trended in ‘bullish’ territory amid ‘high’ message volume.&nbsp;A Stocktwits user praised the company's earnings and said that GME "straight up crushed EPS”.&nbsp;<stembedurl>https://stocktwits.com/TheNeighborhoodSancho/message/648442142</stembedurl>Shares in the company have jumped 12.6% so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The GameStop logo is being displayed on a smartphone with GameStop visible in the background. (Photo by Jonathan Raa/NurPhoto via Getty Images)

Why Is GameStop Stock Nosediving Today?

The company reported a decline in its fourth quarter net sales that also missed analyst expectations according to data from Stocktwits. 

Should iShares Core S&P Mid-Cap ETF (IJH) Be on Your Investing Radar?

<ul class="summary-bullets"><li>The acquisition is subject to customary closing conditions and certain third-party approvals, including approval by Fannie Mae and Freddie Mac.</li><li>Zions will now be able to offer its clients an expanded product suite through its participation in a variety of important lending programs, including the Fannie Mae DUS program.&nbsp;</li></ul>Zions Bancorp (ZION) on Monday said that it has entered into a definitive agreement to acquire the agency lending business of Basis Multifamily Finance I, LLC, a subsidiary of Basis Investment Group, which includes its experienced team, access to agency lending programs, and all associated mortgage servicing rights.Shares of Zions jumped during extended hours of trading and was up 3% at the time of writing. The acquisition is subject to customary closing conditions and certain third-party approvals, including approval by Fannie Mae and Freddie Mac.&nbsp;The company did not disclose the value of the deal.&nbsp;<h2 class="st-heading-2">Deal Details</h2>In connection with the acquisition, Zions and Basis have entered into a strategic partnership that will expand each respective company's real estate financing and capital formation efforts.“The acquisition of Basis' agency lending business will strategically expand our capabilities to meet the needs of our commercial real estate customers. This is a natural, customer-driven evolution of our capital markets strategy, which continues to be a meaningful growth engine for the company,” said Harris Simmons, Chairman and CEO of Zions Bancorporation.“This transaction is a great result for all stakeholders, enabling the agency platform to scale while driving financing and investment activity across Basis' diversified Funds platform through our ongoing partnership with Zions,” said Tammy K. Jones, CEO and Founder of Basis.By acquiring Basis' agency lending business, Zions will be able to offer its clients an expanded product suite through its participation in a variety of important lending programs, including the Fannie Mae DUS program, and the Freddie Mac Optigo Conventional and Small Balance Loan programs.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around ZION trended in ‘neutral’ amid ‘normal’ message volume.&nbsp;Shares in the company have fallen 6% so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

US-Dollar banknotes and model of a privately owned house.

Zions Bancorp Stock Is Rising After-Hours – Know Why

Zions and Basis have entered into a strategic partnership that will expand each respective company's real estate financing and capital formation efforts.

Shares of Five Below Inc. (FIVE) jumped 7% after hours on Wednesday after the company reported fourth-quarter (Q4) earnings and revenue numbers above Wall Street expectations, while also dismissing the impact of tariffs on the company’s supply chain going forward.The discount store company, which mostly sells items priced between $1 and $5, now expects FY26 earnings per share in the range of $7.74-$8.25 and revenue of $5.2 billion to $5.3 billion. Wall Street, on average, was expecting revenue of $5.2 billion and earnings per share of $6.96.Same store sales are expected to increase by about 3% to 5% in the period while the company opens about 150 net new stores.<h2 class="st-heading-2">Management Perspective</h2>“Looking ahead, we are focused on delivering trend-right merchandise at exceptional value... With a growing store base, strong new store performance, and a differentiated customer value proposition, we believe we are well positioned to drive sustainable sales growth, margin expansion, and long-term shareholder value.” Winnie Park, CEO of Five Below, said.The company also expressed optimism for tariffs not impacting its supply chain going forward. &nbsp;“...last year we had the tariffs hit us, and so we weren't able to actually buy or attain all the products that we wanted to fill out some of our worlds. This year, that is not an obstacle,” an executive said during the company’s post-earnings call with analysts.Q4 NumbersIn the fourth quarter, same store sales increased by 15.4%, pushing revenue for the period up 24.3% to $1.73 billion. Adjusted earnings for the period came in at $4.31 compared to $3.48 in the corresponding quarter of fiscal 2024, and above an estimated $4, according to data from Fiscal.ai.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around FIVE stock stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume remained ‘high’.<a href="https://stocktwits.com/symbol/FIVE">FIVE stock</a> has gained 187% over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/logi-stock-rises-after-hours-on-1.4-billion-share-buyback-program/cZ37Fl6RIWI">LOGI Stock Rises After Hours On $1.4B Share Buyback Program</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Logo of the Five Below store in Roseville, Minnesota. Source: : Michael Siluk/UCG/Universal Images Group via Getty Images

FIVE Stock Soars After Upbeat Q4 Results — Here’s What Management Said About Tariff Impact

The discount store company, which mostly sells items priced between $1 and $5, now expects FY26 earnings per share in the range of $7.74-$8.25 and revenue of $5.2-$5.3 billion.

Lantheus Holdings, Inc. (LNTH) said on Tuesday that the U.S. Food and Drug Administration has extended its review of LNTH-2501 by three months.Shares of the company slipped marginally after hours at the time of writing.<h2 class="st-heading-2">Why The Delay?</h2>The agency is now slated to decide on the radiopharmaceutical-focused company’s application seeking approval for the diagnostic kit by June 29. The extended deadline is expected to give the agency additional time to review and consider further manufacturing related information submitted by Lantheus, it said.The extension, however, is not related to the efficacy or safety data of LNTH-2501, a radioactive diagnostic kit for for use with positron emission tomography (PET) for detecting somatostatin receptor positive neuroendocrine tumors in adults as well as pediatric patients, the company added.LNTH-2501 is not available in the U.S. yet.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around LNTH stock stayed within the ‘extremely bearish’ territory while message volume fell from ‘high’ to ‘normal’ levels.According to data from Koyfin, the 12-month average price target on the stock is at $91, representing a potential upside of about 13%. Of the 13 analysts covering the stock, 11 rate it ‘Buy’ or higher while two rate it a ‘Hold.’Earlier this month, Lantheus announced that the FDA approved its PYLARIFY TruVu injection. The injection is indicated for imaging certain lesions in men with prostate cancer, the second most common form of cancer affecting men in the U.S. It is now expected to be commercially available in the fourth quarter of 2026.<a href="https://stocktwits.com/symbol/LNTH">LNTH stock</a> has slipped 22% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lulu-shares-fall-despite-board-reshuffle-as-2026-outlook-misses-street-expectations/cZ3EZeyRIXz">LULU Shares Fall Despite Board Reshuffle As 2026 Outlook Misses Street Expectations</a>Get updates to this developing story directly on Stocktwits.

In this photo illustration, the Lantheus Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application

LNTH Stock - Lantheus Holdings, Inc. (LNTH) said on Tuesday that the U.S. Food and Drug Administration has extended its review of LNTH-2501 by three months.

The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29.


<ul class="summary-bullets"><li>UiPath will report quarterly results after the markets close on Wednesday.</li><li>Traders are keenly watching high short interest, anticipating a massive squeeze and significant upside potential post-earnings.</li><li>Stocktwits sentiment for PATH jumped to ‘extremely bullish’ from ‘bullish.’</li></ul>Retail sentiment for UiPath, Inc.&nbsp;on Stocktwits climbed sharply higher even as the stock broke its five-day winning streak on Tuesday, ahead of its fourth-quarter report.&nbsp;The retail trading community on the platform believes that rising short positions pressured PATH stock, although many expect a strong earnings report on Wednesday, which could prompt a short squeeze. A short squeeze occurs when a heavily shorted stock rises sharply, forcing short sellers to buy back shares and pushing the price even higher.&nbsp;UiPath is among the key stocks investors are watching amid rising enterprise adoption of AI tools. The company offers software that automates repetitive, time-consuming business tasks, such as filling out forms, extracting information from documents, and generating reports – also known as Robotic Process Automation (RPA).&nbsp;Over the past year, it has doubled down on its shift to AI-driven, agentic automation, rolling out new tools such as Agent Builder and deepening partnerships with players including OpenAI, SAP, and Deloitte.PATH Stock Move<a href="https://stocktwits.com/symbol/PATH">UiPath shares</a> dropped 3.2% on Tuesday, though they recouped part of the loss in the after-hours session. They’ve been on a sharp upward trajectory, rising by over 16% over the past nine sessions, though they are still down about 30% year to date.Notably, short interest in shares has risen to a record 15.7% from 7.9% in mid-December, per Koyfin data.&nbsp;<h2 class="st-heading-2">Retail’s View On PATH</h2>Stocktwits sentiment for the stock shifted to ‘extremely bullish’ as of late Tuesday, from ‘bullish’ the previous day.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_11_at_7_15_44_AM_png_6aae7641ef.webp" alt="Screenshot 2026-03-11 at 7.15.44 AM.png" width="699" height="85"><figcaption>PATH sentiment and message volume as of March 10 | Source: Stocktwits</figcaption></figure>“For a red day after many green ones, I can not complain, as it was only 3%. Tomorrow is the big day. $15 plus on a good report!”&nbsp;<a href="https://stocktwits.com/TheDizPlinTrader/message/647158950">said</a> a user.Another&nbsp;<a href="https://stocktwits.com/fundamentalCo/message/647091456">said</a>: “60%+ short squeeze with a stellar FY result and improved guidance is completely possible with 20%+ short interest, let’s go!”&nbsp;Some traders held a different view, owing to the same short positions and the news that chip giant Nvidia is reportedly planning to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-s-next-ai-bet-report-says-nemo-claw-could-power-enterprise-ai-agents/cZdoNuERIes">launch an agentic AI platform</a>.&nbsp;“It's very risky and with nvda news out the whole software sector is back to tanking mode and It's a longer term event. Strong sell imo,”&nbsp;<a href="https://stocktwits.com/Darth_Bearius/message/647113437">said</a> a bearish user.<h2 class="st-heading-2">PATH Earnings Watch, Recent Updates</h2>Analysts expect revenue to rise nearly 10% to $464.8 million, per Koyfin, when the company reports its fourth-quarter results after the markets close on Wednesday. Adjusted profit is expected to decline 2% to $0.25 per share.UiPath&nbsp;won a spot in the S&amp;P 400 at the start of the year. Meanwhile, CEO and Chairman Daniel Dines sold over $4 million worth of shares in January 2026 and December 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 A UiPath logo seen displayed on a smartphone with stock market percentages in the background. 

PATH Stock Snaps 5-Day Winning Streak — Why Retail Sentiment Is Surging Ahead Of Q4 Earnings

UiPath’s Short interest has climbed to 15.7%, nearly double mid-December levels, prompting some traders to expect a short squeeze if the earnings report beats expectations.

<ul class="summary-bullets"><li>AVAV’s net loss for Q3 of fiscal 2026 was $156.6 million, or $3.15 loss per diluted share, as compared to net loss of $1.8 million, or $0.06 loss per diluted share from the year-ago period.</li><li>The company's third quarter results were impacted by revenue timing and adjustments in its Space business, the CEO said.&nbsp;</li></ul>Aerovironment stock plummeted 8% during after-hours trading on Tuesday after its weak third quarter revenue for fiscal 2026 and&nbsp;widening quarterly loss spurred a selloff in the stock.It reported third quarter revenue of $408.0 million which fell well short of analyst expectations of $475.65 million, as per data from Fiscal.ai.However, revenue increased 143% as compared to $167.6 million for the third quarter of fiscal 2025, due to higher product sales of $138.1 million and higher service revenue of $102.3 million.“While our third quarter results were impacted by revenue timing and adjustments in our Space business, demand for our unique solutions remains robust,” said Wahid Nawabi, AeroVironment chairman, president and chief executive officer.“Strong order flow and growth in funded backlog during the quarter are setting the stage for record fourth quarter revenue and a solid start to fiscal year 2027. We are executing with discipline, scaling manufacturing ahead of demand and accelerating the commercialization of our platforms to improve profitability and time to market,” Nawabi said.&nbsp;<h2 class="st-heading-2">More Details</h2>Net loss for the third quarter of fiscal 2026 was $156.6 million, or $3.15 loss per diluted share, as compared to net loss of $1.8 million, or $0.06 loss per diluted share, in the prior-year period, respectively. The current quarter was negatively impacted by goodwill impairment charges of $151.3 million.&nbsp;In January, the company received a stop-work order on its&nbsp;deal for the delivery of BADGER phased array antenna systems to support Space Force’s Satellite Communication Augmentation Resource (“SCAR”) program.&nbsp;The U.S. Space Force earlier in the month announced that it is putting the Satellite Communications Augmentation Resource program back up for competition, which significantly affected AVAV’s backlog.&nbsp;Gross margin for the third quarter of fiscal 2026 was $98.8 million, an increase of 56% as compared to $63.2 million for the third quarter of fiscal 2025, reflecting higher product margin of $19.1 million and higher service margin of $16.5 million.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around AVAV stock trended in ‘bullish’ territory amid ‘high’ message volume.&nbsp;Shares in the company have fallen 20.3% year-to-date.&nbsp;

AeroVironment exhibited during the Defense Expo Korea 2022, held at KINTEX (Korea International Exhibition and Convention Center) on September 21, 2022 in Goyang city, Gyeonggi, South Korea. 

AVAV Stock Plummets As Q3 Revenue Comes Way Below Wall Street Expectations, Triggering Selloff

It reported third quarter revenue of $408.0 million which fell well short of analyst expectations of $475.65 million, as per data from Fiscal.ai.

<ul class="summary-bullets"><li>MTN reported Q2 fiscal 2026 net income attributable to Vail Resorts of $210.0 million compared to $244.4 million in the prior year.&nbsp;</li><li>Due to the persistent, historically challenging weather conditions in the Rockies, which continued to limit terrain availability, the&nbsp;company&nbsp;is reducing its fiscal 2026 guidance, MTN’s CEO noted.&nbsp;</li><li>The company now expects net income attributable to Vail Resorts of $144 million to $190 million for its FY 2026.&nbsp;</li></ul>Vail Resorts shares fell in extended hours of trading on Monday after its second quarter revenue of its FY 2026 fell compared to the year-ago quarter&nbsp;and missed analysts’ expectations.&nbsp;The company reported total net revenue of $1.08 billion during the reported quarter, down from $1.13 billion it reported year-ago. Analysts, on average, had expected revenue of $1.11 billion, as per from Fiscal.ai data.&nbsp;"This has been the most challenging winter across the Rockies that we have ever experienced with the lowest snowfall levels in more than 30 years for our Colorado and Utah resorts, combined with warmer temperatures, resulting in reduced terrain throughout the quarter and into February,” said Rob Katz, Chief Executive Officer, Vail Resorts.&nbsp;“While these conditions and the resulting visitation headwinds negatively impacted our quarterly results, we remained focused on the areas within our control. This includes our advanced commitment strategy, continued investments in our resorts and our employees, and progressing key initiatives to optimize visitation, including enhanced marketing and new products,” he added.&nbsp;<h2 class="st-heading-2">Q2 2026 Snapshot</h2>Vail Resorts reported Q2 fiscal 2026 net income attributable of $210.0 million compared to $244.4 million in the prior year.&nbsp;Its resort net revenue decreased $53.2 million, or 4.7%, compared to the prior year, which was primarily driven by the unfavorable weather conditions that impacted visitation and ancillary spending for both local and destination guests during the period.<h2 class="st-heading-2">Cuts 2026 Guidance</h2>The company now expects net income attributable to Vail Resorts, Inc. of $144 million to $190 million for its FY 2026.&nbsp;"Due to the persistent, historically challenging weather conditions in the Rockies, which continued to limit terrain availability, the Company is reducing its fiscal 2026 guidance. While we are lowering our estimates for the fiscal year, given the unprecedented weather in the Rockies, the impact from conditions was mitigated by our advance commitment strategy and resource transformation efforts,” Katz said.&nbsp;<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around MTN stock trended in ‘bearish’ territory amid ‘extremely high’ message volume.Shares in the company have been flat so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Vail Resorts shares fell in extended hours of trading on Monday after its second quarter revenue of its FY 2026

Vail Resorts Earnings And 2026 Guidance Cut Kills Investor Optimism

The company reported total net revenue of $1.08 billion during the reported quarter, down from $1.13 billion it reported year-ago.

iShares Trust - iShares Core S&P Mid-Cap ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

IJH
iShares Core S&P Mid-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IJH News

IJHiShares Core S&P Mid-Cap ETF